PHQ-9 Depression Test
Take the Patient Health Questionnaire-9 (PHQ-9), the gold standard depression screening tool used by healthcare professionals worldwide. Get instant, confidential results.
Clinically Validated
Used by healthcare professionals worldwide
What is the PHQ-9 Depression Test?
Understanding the Patient Health Questionnaire-9 and its role in depression screening
Expert Overview
The Patient Health Questionnaire-9 (PHQ-9) is a multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. It incorporates DSM-IV depression diagnostic criteria with other leading major depressive symptoms into a brief self-report tool.
Developed by Dr. Robert Spitzer and colleagues, the PHQ-9 has become the most widely used depression screening tool in primary care settings worldwide, with extensive validation across diverse populations and healthcare settings.
Clinically Validated
The PHQ-9 has been validated in over 6,000 patients in primary care settings and has shown excellent reliability and validity for detecting major depression.
Globally Recognized
Used by healthcare professionals in over 50 countries and translated into more than 30 languages, making it the international standard for depression screening.
PHQ-9 Scoring and Interpretation
Understanding how the PHQ-9 depression test is scored and what your results mean
PHQ-9 Depression Severity Levels
| PHQ-9 Score | Depression Severity | Recommended Action | Functional Impairment |
|---|---|---|---|
| 0-4 | Minimal | Monitor symptoms; no treatment needed | None to minimal |
| 5-9 | Mild | Watchful waiting; lifestyle modifications | Mild functional impairment |
| 10-14 | Moderate | Treatment plan; counseling or medication | Moderate functional impairment |
| 15-19 | Moderately Severe | Active treatment with medication and/or therapy | Significant functional impairment |
| 20-27 | Severe | Immediate treatment; consider hospitalization | Severe functional impairment |
Clinical Interpretation Guidelines
The PHQ-9 score provides a reliable measure of depression severity, but clinical judgment should always be used in conjunction with the score. Factors to consider include:
- Functional impairment: How symptoms affect daily activities, work, and relationships
- Duration of symptoms: Symptoms present for at least 2 weeks for major depression diagnosis
- Suicidal ideation: Any positive response to question 9 requires immediate assessment
- Medical conditions: Rule out medical causes of depressive symptoms
- Substance use: Consider impact of alcohol or drug use on symptoms
Note: A PHQ-9 score ≥10 has a sensitivity of 88% and specificity of 88% for major depression.
Take the PHQ-9 Depression Test
Complete the 9-question assessment to screen for depression symptoms
PHQ-9 Research and Development
The scientific foundation and clinical validation of the PHQ-9 depression test
Scientific Background
The PHQ-9 was developed as part of the larger Patient Health Questionnaire (PHQ) by Dr. Robert Spitzer, Dr. Janet Williams, and Dr. Kurt Kroenke in the late 1990s. The development was funded by Pfizer Inc. and aimed to create a brief, self-administered diagnostic tool for common mental disorders in primary care settings.
The original validation study, published in the Journal of General Internal Medicine in 2001, included 6,000 patients from 8 primary care clinics and 7 obstetrics-gynecology clinics. The study demonstrated that the PHQ-9 had excellent reliability (Cronbach's α = 0.89) and validity for detecting major depression.
Since its initial publication, the PHQ-9 has been cited in over 10,000 peer-reviewed research articles and has been validated across numerous populations, age groups, and cultural contexts worldwide.
Diagnostic Accuracy
- Sensitivity: 88% (correctly identifies depression)
- Specificity: 88% (correctly rules out depression)
- Positive Predictive Value: 53% at cutoff ≥10
- Negative Predictive Value: 98% at cutoff ≥10
Population Studies
- Primary Care: Validated in 6,000+ patients
- Adolescents: Effective for ages 13-17
- Elderly: Validated in geriatric populations
- Cultural Adaptation: 30+ language versions
Professional Recognition and Guidelines
The PHQ-9 is recommended by major medical organizations and included in clinical practice guidelines worldwide:
- American Psychiatric Association: Recommended in DSM-5 for depression severity assessment
- U.S. Preventive Services Task Force: Endorsed for depression screening in adults
- National Institute for Health and Care Excellence (NICE): Recommended in UK depression guidelines
- World Health Organization: Included in mhGAP intervention guide
- American Academy of Family Physicians: Recommended for primary care screening
The PHQ-9 is also integrated into major electronic health record systems and is used in quality improvement initiatives across healthcare systems globally.
PHQ-9 vs Other Depression Screening Tools
How the PHQ-9 compares to other commonly used depression assessment instruments
| Assessment Tool | Questions | Time to Complete | Primary Use | Advantages |
|---|---|---|---|---|
| PHQ-9 | 9 items | 2-3 minutes | Screening & severity | Brief, validated, DSM-aligned |
| Beck Depression Inventory (BDI-II) | 21 items | 5-10 minutes | Severity assessment | Comprehensive, well-established |
| Hamilton Depression Rating Scale (HAM-D) | 17-21 items | 15-20 minutes | Clinical assessment | Clinician-administered, detailed |
| Geriatric Depression Scale (GDS) | 15-30 items | 5-10 minutes | Elderly populations | Age-specific, yes/no format |
| Center for Epidemiologic Studies Depression Scale (CES-D) | 20 items | 5-10 minutes | Research & screening | Population studies, free use |
Why Choose the PHQ-9?
The PHQ-9 has become the preferred depression screening tool in many healthcare settings due to several key advantages:
- Brevity: Only 9 questions, completed in 2-3 minutes
- DSM Alignment: Questions directly correspond to DSM-5 criteria
- Dual Purpose: Both screening and severity measurement
- Free Access: No licensing fees or restrictions
- Self-Administered: No need for trained interviewer
- Widely Validated: Extensive research across populations
- Treatment Monitoring: Useful for tracking progress
- Electronic Integration: Easy to implement in EHR systems
Frequently Asked Questions About the PHQ-9
Common questions about the PHQ-9 depression test answered by mental health experts
PHQ-9 stands for Patient Health Questionnaire-9. It is a 9-question screening tool that measures the severity of depression symptoms based on the nine DSM-IV criteria for major depressive disorder.
The PHQ-9 assesses symptoms such as depressed mood, anhedonia (loss of interest), sleep disturbances, fatigue, appetite changes, feelings of worthlessness, concentration problems, psychomotor changes, and suicidal ideation over the past two weeks.
The PHQ-9 is highly accurate for screening depression, with a sensitivity of 88% and specificity of 88% when using a cutoff score of 10 or higher. This means it correctly identifies 88% of people with depression and correctly rules out depression in 88% of people without the condition.
However, it's important to note that the PHQ-9 is a screening tool, not a diagnostic instrument. A positive screen should always be followed by a comprehensive clinical evaluation by a qualified healthcare professional for an official diagnosis.
PHQ-9 scores are interpreted as follows:
- 0-4: Minimal depression
- 5-9: Mild depression
- 10-14: Moderate depression
- 15-19: Moderately severe depression
- 20-27: Severe depression
A score of 10 or higher is typically considered the threshold for clinically significant depression that warrants further evaluation and potential treatment. However, clinical judgment should always be used alongside the score.
Yes, the PHQ-9 is excellent for monitoring treatment progress. It's sensitive to changes in depression severity over time, making it valuable for tracking how well treatments are working.
A reduction of 5 points or more on the PHQ-9 is considered clinically significant improvement. Many healthcare providers use the PHQ-9 at regular intervals (such as every 2-4 weeks) during treatment to assess progress and adjust treatment plans as needed.
The PHQ-9 is also used in measurement-based care approaches, where treatment decisions are guided by objective symptom measurements rather than clinical impression alone.
The PHQ-9 has been validated for use in adolescents (ages 13-17) and adults of all ages, including elderly populations. However, some considerations apply:
- Adolescents: The PHQ-A (adolescent version) may be more appropriate for teens
- Elderly: May need assistance with completion; consider cognitive status
- Children under 13: Not validated; other tools like the Children's Depression Inventory may be more appropriate
The PHQ-9 has also been adapted and validated across many different cultural and linguistic groups, with translations available in over 30 languages.
If you score 10 or higher on the PHQ-9, it's important to take the following steps:
- Consult a healthcare professional: Schedule an appointment with your primary care doctor or a mental health specialist
- Don't ignore the results: High scores indicate significant symptoms that deserve attention
- Seek immediate help if needed: If you endorsed suicidal thoughts (question 9), contact a crisis helpline or emergency services
- Consider lifestyle factors: Evaluate sleep, exercise, stress, and social support
Remember that depression is a treatable condition, and effective treatments including therapy, medication, and lifestyle changes are available. Early intervention often leads to better outcomes.
Ready to Take the PHQ-9 Depression Test?
Use the clinically validated PHQ-9 to assess your depression symptoms and get professional-grade results
Take PHQ-9 Test Now